Harbinger | $100,000,000 | (Jan 15, 2025)
Lady Technologies | $6,500,000 | (Jan 15, 2025)
LetsData | $1,600,000 | (Jan 15, 2025)
Certified by Founder
Lodge
OrsoBio
start up
United States
- Palo Alto, CA
- 08/11/2023
- Series A
- $60,000,000
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
- Industry Biotechnology Research
- Website https://orsobio.com/
- LinkedIn https://www.linkedin.com/company/orsobio/about/
Orchid Security | $36,000,000 | (Jan 15, 2025)
The Snow League | $15,000,000 | (Jan 15, 2025)
Nelly Solutions | $51,555,959 | (Jan 15, 2025)
Enhanced Medical Nutrition | $5,000,000 | (Jan 15, 2025)
OrbitAID Aerospace | $1,500,000 | (Jan 15, 2025)
Clear Labs | $30,000,000 | (Jan 14, 2025)
XtremeX Mining Technology | $11,000,000 | (Jan 14, 2025)
Yampa | $3,078,059 | (Jan 14, 2025)
nsave | $18,000,000 | (Jan 14, 2025)